source
- FDA acting chief says two journal articles by former commissioner do not represent agency policyActing FDA Commissioner Kyle Diamantas announced that the agency is reversing its earlier position regarding two medical‑journal articles authored by former commissioner Marty Makary. The FDA now…
- Johnson & Johnson to spend up to $750 million restructuring pharma manufacturing and closing plantsJohnson & Johnson announced it will incur up to $750 million as it reshapes its pharmaceutical manufacturing network. The plan involves exiting certain factories and consolidating production, aimi…